Literature DB >> 20569187

Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation.

Jan Schulte Am Esch1, Kerstin Jurk, Wolfram T Knoefel, Gesine Roeder, Holger Voss, Roy Y Tustas, M Schmelzle, Andreas Krieg, Claus F Eisenberger, Stefan Topp, Xavier Rogiers, Lutz Fischer, Hugo Van Aken, Beate E Kehrel.   

Abstract

Platelets have been implicated in the pathogenesis of liver damage after orthotopic liver transplantation (OLT). Early graft dysfunction is frequently caused by reperfusion injury subsequent to cold ischemia (IRI). Therefore, we investigated activation of the pivotal haemostatic cells, platelets and monocytes, from patients with elevated markers of IRI and from patients with uneventful course (control-group), respectively during the first week after OLT. Flow cytometry analysis of citrate anticoagulated blood samples revealed that platelets from IRI patients became significantly activated within 48 h after OLT in vivo, with increased surface presentation of P-selectin, CD40L, thrombospondin-1 and tissue-factor. Platelet activation in IRI patients on post-transplant day 2 was accompanied by significantly enhanced tissue-factor expression on peripheral blood monocytes, significant elevated levels of C-reactive protein and hepatocellular damage. Towards post-transplant day 4, levels of platelet-derived microparticles rose significantly in IRI patients if contrasted to control patients. Thus, activated cellular haemostasis is involved in the early inflammatory response of hepatocellular damage subsequent to reperfusion of the transplanted liver. Targeting distinct activation patterns of platelets and monocytes in an early phase of hepatic grafting may counteract the extent of IRI via inhibition of micro-thrombus formation and inflammation without exacerbating the existing bleeding risk.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20569187     DOI: 10.3109/09537101003739897

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  11 in total

Review 1.  Which anti-platelet therapies might be beneficial in xenotransplantation?

Authors:  Moritz Schmelzle; Peter J Cowan; Simon C Robson
Journal:  Xenotransplantation       Date:  2011 Mar-Apr       Impact factor: 3.907

2.  How to protect liver graft with nitric oxide.

Authors:  Hassen Ben Abdennebi; Mohamed Amine Zaoualí; Izabel Alfany-Fernandez; Donia Tabka; Joan Roselló-Catafau
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

Review 3.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

Review 4.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

5.  Identifying independent risk factors for graft loss after primary liver transplantation.

Authors:  Jill Gwiasda; Harald Schrem; Jürgen Klempnauer; Alexander Kaltenborn
Journal:  Langenbecks Arch Surg       Date:  2017-06-01       Impact factor: 3.445

Review 6.  miRNA Involvement in Cerebral Ischemia-Reperfusion Injury.

Authors:  Maria-Adriana Neag; Andrei-Otto Mitre; Codrin-Constantin Burlacu; Andreea-Ioana Inceu; Carina Mihu; Carmen-Stanca Melincovici; Marius Bichescu; Anca-Dana Buzoianu
Journal:  Front Neurosci       Date:  2022-06-10       Impact factor: 5.152

7.  Tumor Necrosis Factor-α: Life and Death of Hepatocytes During Liver Ischemia/Reperfusion Injury.

Authors:  Maureen Shuh; Humberto Bohorquez; George E Loss; Ari J Cohen
Journal:  Ochsner J       Date:  2013

8.  Association between the perioperative antioxidative ability of platelets and early post-transplant function of kidney allografts: a pilot study.

Authors:  Barbara Dołęgowska; Wojciech Błogowski; Leszek Domański
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

9.  Thromboelastographic Evaluation of Coagulation in Patients With Liver Disease.

Authors:  Kyung Hwa Shin; In Suk Kim; Hyun Ji Lee; Hyung Hoi Kim; Chulhun L Chang; Young Mi Hong; Ki Tae Yoon; Mong Cho
Journal:  Ann Lab Med       Date:  2017-05       Impact factor: 3.464

10.  Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597).

Authors:  Narci C Teoh; Hussam Ajamieh; Heng Jian Wong; Kevin Croft; Trevor Mori; Anthony C Allison; Geoffrey C Farrell
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.